A Florida appellate court has reversed a lower court's decision to dismiss a lawsuit filed by Medicability, LLC against Blue Hill Buffalo Consulting, LLC. The court found that the lower court erred in applying the doctrine of res judicata, which bars claims that have already been judged in a previous case. This ruling allows Medicability to move forward with its claims against Blue Hill, which include breach of contract and fraudulent inducement.

The case, Medicability, LLC, as Assignee of Strategic Solutions Consulting Group, LLC v. Blue Hill Buffalo Consulting, LLC, was filed in the District Court of Appeal of Florida under docket number 2D21-2314. The decision was issued on December 2, 2022, and it affects Medicability, a company that acted as an agent for Strategic Solutions Consulting Group, LLC, in a contract with Blue Hill.

Background

Medicability, LLC, is an agent for Strategic Solutions Consulting Group, LLC. In July 2020, Strategic Solutions entered into a contract with Blue Hill Buffalo Consulting to supply personal protective equipment, specifically nitrile gloves, to the Cleveland Clinic during the COVID-19 pandemic. Although Medicability was not named in the contract, it acted on behalf of Strategic Solutions in the transaction.

The contract stipulated that Blue Hill would sell 38,300 boxes of nitrile gloves for a total of $536,200. Medicability made the payment to Blue Hill, but the delivery of the gloves was delayed. Blue Hill claimed the gloves were stuck in customs, but ultimately, the delivery did not occur as promised.

In November 2020, Medicability filed a complaint against Blue Hill, alleging several claims, including negligent representation and fraud. However, the trial court dismissed this complaint with prejudice, stating that Medicability lacked standing to sue as it was not a party to the contract. Medicability did not appeal this dismissal.

In April 2021, Medicability filed a new complaint, this time as an assignee of Strategic Solutions. This complaint alleged breach of contract and fraudulent inducement against Blue Hill. Blue Hill responded by filing a motion to dismiss based on res judicata, arguing that the claims were barred because they were similar to those in the 2020 complaint.

The Ruling

The District Court of Appeal of Florida reviewed the case and found that the trial court had erred in dismissing Medicability's 2021 complaint. The court noted that the doctrine of res judicata applies only when there is an identity of the parties, the cause of action, and the quality or capacity of the persons involved. In this case, the court found that while the first three identities were present, the identity of capacity was not.

The court ruled, "there is no identity of capacity between the plaintiff in the first lawsuit and the plaintiff in the second lawsuit."

The appellate court explained that in the first lawsuit, Medicability was seeking damages for its own claims, while in the second lawsuit, it was acting as an assignee of Strategic Solutions, seeking damages that were distinct and based on the contractual rights of the assignor. The court emphasized that the identity of capacity does not exist if the plaintiff is suing in a different capacity in the second lawsuit.

The judges on the panel, including Judge Atkinson, Chief Judge Morris, and Judge Smith, concurred with the decision to reverse the lower court's dismissal.

Impact

This ruling has significant implications for Medicability as it allows the company to pursue its claims against Blue Hill without the barrier of res judicata. The decision clarifies that a party can bring a new lawsuit in a different capacity, even if the underlying facts are similar to a previous case. This ruling could set a precedent for future cases where parties seek to assert claims based on different legal capacities.

Moreover, the case highlights the importance of understanding the nuances of standing and capacity in legal disputes. Companies and individuals involved in contractual agreements should be aware that their rights may vary depending on their role in the transaction.

What's Next

With the appellate court's ruling, Medicability can now proceed with its claims against Blue Hill in the lower court. The case may lead to further legal proceedings, including potential settlement discussions or a trial. There is no indication in the court filing that the decision will be appealed further.